Shanghai Runda Medical Technology Co., Ltd. (SHA:603108)

Market Cap	10.46B
Revenue (ttm)	7.90B
Net Income (ttm)	-36.58M
Shares Out	603.65M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	25.10
Dividend	0.10 (0.57%)
Ex-Dividend Date	n/a

Volume	12,418,810
Average Volume	16,916,825
Open	17.65
Previous Close	17.65
Day's Range	17.24 - 17.65
52-Week Range	11.77 - 24.91
Beta	0.40
RSI	43.31
Earnings Date	Aug 29, 2025

About SHA:603108

Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables; medical solutions to help healthcare professionals in the areas of diabetes, POCT, clinical chemistry, and immunoassay; professional technical services; and logistic services. In addition, it is involved in the software development; provision of information system integration and consulting ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 3,137
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603108

Financial Performance

In 2024, SHA:603108's revenue was 8.31 billion, a decrease of -9.13% compared to the previous year's 9.15 billion. Earnings were 55.28 million, a decrease of -79.77%.